ADP-ribosylation (ADPRylation) is a fundamental and evolutionarily conserved post-translational modification (PTM) where the ADP-ribose (ADPr) moiety from nicotinamide adenine dinucleotide (NAD+) is transferred onto acceptor molecules, primarily proteins.1 This process, releasing nicotinamide (NAM) as a byproduct, plays critical roles in a vast array of cellular functions, including the maintenance of genome stability, transcriptional regulation, chromatin dynamics, cell cycle control, inflammation, metabolism, and cell death signaling.3 ADPRylation exists in two major forms: mono-ADPRylation (MARylation), the attachment of a single ADPr unit, and poly-ADPRylation (PARylation), the...
The enzymatic machinery responsible for ADPRylation comprises the Poly(ADP-ribose) Polymerase (PARP) superfamily, also known as ADP-ribosyltransferases Diphtheria toxin-like (ARTDs).3 In humans, this family encompasses approximately 17-18 members encoded by distinct genes, all sharing homology within a conserved catalytic domain.2 Despite the family name, the capacity for PAR synthesis (PARylation) is confirmed for only a subset of these enzymes: PARP1, PARP2, PARP5a (Tankyrase 1), and PARP5b (Tankyrase 2).3 Most other members catalyze MARylation or have yet undetermined enzymatic activity.3